Evidence map›Paper›PMID 34322018›Full record

ArticleFrontiers in pharmacology2021

A Survey of Pharmacogenomics Testing Among Physicians, Pharmacists, and Researchers From China.

Chengxian Guo, Biwen Hu, Chengjun Guo, Xiangguang Meng, Yun Kuang, Longjian Huang, Danling Wang, Kangwei Xu, Yanlin Zhao, Guoping Yang and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Toward Integration of Pharmacogenomic Tests into Daily Clinical Practice: A General Survey for Polish Healthcare Workers.Medical science monitor : international medical journal of experimental and clinical research · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Evolution ofFrontiers in pharmacology · 2022
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Chengxian GuoCenter of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, China.
Biwen HuCenter of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, China.
Chengjun GuoSchool of Applied Mathematics, Guangdong University of Technology, Guangzhou, China.
Xiangguang MengLaboratory of Cardiovascular Disease and Drug Research, Zhengzhou No. 7 People's Hospital, Zhengzhou, China.
Yun KuangCenter of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, China.
Longjian HuangYoujiang Medical University for Nationalities, Baise, China.
Danling WangDepartment of Neuroscience, Hengyang School of Medicine, University of South China, Hengyang, China.
Kangwei XuHunan Normal University School of Medicine, Changsha, China.
Yanlin ZhaoCenter of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, China.
Guoping YangCenter of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, China.
Weimin CaiDepartment of Clinical Pharmacy, School of Pharmacy, Fudan University, Shanghai, China.
Yan ShuDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Maryland at Baltimore, Baltimore, MD, United States.
Guangdong University of Technology · CNCentral South University · CNUniversity of Maryland, Baltimore · USAffiliated Hospital of Youjiang Medical University for Nationalities · CNFudan University · CNHunan Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To elucidate current domestic factors influencing pharmacogenomics (PGx) implementation and its future in China, we conducted a questionnaire survey on PGx applications and testing. A questionnaire-based survey was created on the popular online professional survey platform "Wenjuanxing" (www.wjx.cn) and performed

Indexed as

clinical Pharmacologygenomicspharmacogeneticspharmacogenomicssurvey

Identifiers

PMID34322018
PMCPMC8311355
OpenAlexW3179846157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.